{"id":"ampicillin-sulbactam","safety":{"commonSideEffects":[{"rate":"3-10%","effect":"Diarrhea"},{"rate":"3-5%","effect":"Nausea"},{"rate":"1-3%","effect":"Vomiting"},{"rate":"1-3%","effect":"Rash"},{"rate":"1-2%","effect":"Allergic reactions"},{"rate":"<1%","effect":"Pseudomembranous colitis"}]},"_chembl":{"chemblId":"CHEMBL1200758","moleculeType":"Small molecule","molecularWeight":"371.39"},"_dailymed":{"setId":"dc374fa4-350b-425d-a7db-7099fdc64cf1","title":"AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM AND SULBACTAM SODIUM) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ampicillin is a beta-lactam antibiotic that binds to penicillin-binding proteins and disrupts peptidoglycan cross-linking in bacterial cell walls. Sulbactam is a beta-lactamase inhibitor that irreversibly binds and inactivates bacterial beta-lactamase enzymes, preventing them from degrading ampicillin and extending its spectrum to include beta-lactamase-producing organisms.","oneSentence":"Ampicillin inhibits bacterial cell wall synthesis while sulbactam inhibits bacterial beta-lactamase enzymes, together restoring ampicillin's activity against beta-lactamase-producing bacteria.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:27:12.466Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial infections caused by beta-lactamase-producing organisms (skin and soft tissue infections, intra-abdominal infections, gynecological infections)"},{"name":"Respiratory tract infections"},{"name":"Urinary tract infections"}]},"trialDetails":[{"nctId":"NCT07485010","phase":"PHASE2","title":"Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Queensland","startDate":"2027-04","conditions":"Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection, Non-Tuberculous Mycobacterial (NTM) Infections","enrollment":300},{"nctId":"NCT06494072","phase":"PHASE4","title":"Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP","status":"RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2024-08-22","conditions":"Community Acquired Pneumonia in Children","enrollment":236},{"nctId":"NCT07399717","phase":"NA","title":"Assessing Role of Probiotics in Children Aged 6-36 Months Treated for Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"Anabio R&D","startDate":"2026-01-26","conditions":"Pneumonia, Pneumonia in Children","enrollment":330},{"nctId":"NCT06336213","phase":"NA","title":"Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients","status":"RECRUITING","sponsor":"Petrovsky National Research Centre of Surgery","startDate":"2024-01-23","conditions":"Aortic Aneurysm and Dissection, Cardiac Valve Disease, Thoracic Aortic Aneurysm","enrollment":50},{"nctId":"NCT06440304","phase":"PHASE4","title":"Therapeutic Options for CRAB","status":"RECRUITING","sponsor":"Clinical Hospital Centre Zagreb","startDate":"2025-01-30","conditions":"Infections, Bacterial, Sepsis Bacterial","enrollment":108},{"nctId":"NCT07326540","phase":"PHASE3","title":"Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex","status":"NOT_YET_RECRUITING","sponsor":"BioVersys SAS","startDate":"2026-03-20","conditions":"Hospital Acquired Bacterial Pneumonia (HABP), Ventilator Associated Bacterial Pneumonia (VABP), Colistin Resistanrt ABC","enrollment":248},{"nctId":"NCT07318584","phase":"PHASE2","title":"Cefotetan Therapy for Escherichia Coli Infections","status":"NOT_YET_RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2026-03","conditions":"E Coli Infection, ESBL Producing E.Coli","enrollment":84},{"nctId":"NCT06294600","phase":"PHASE3","title":"Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)","status":"RECRUITING","sponsor":"Hellenic Institute for the Study of Sepsis","startDate":"2024-02-12","conditions":"Community-acquired Pneumonia","enrollment":330},{"nctId":"NCT07148622","phase":"NA","title":"Effects of Different Antibiotic Regimens in Preterm Premature Rupture of Membranes","status":"COMPLETED","sponsor":"Yuzuncu Yil University","startDate":"2024-10-01","conditions":"Preterm Premature Rupture of Membranes (PPROM), Prophylaxis, Perinatal Outcomes","enrollment":40},{"nctId":"NCT05977868","phase":"PHASE4","title":"Comparing Oral Versus Parenteral Antimicrobial Therapy","status":"TERMINATED","sponsor":"West Virginia University","startDate":"2023-08-04","conditions":"Endovascular Infection, Bone and Joint Infection, Skin and Soft Tissue Infection","enrollment":94},{"nctId":"NCT07118384","phase":"NA","title":"Comparison of the Clinical Efficacy of Ampicillin/Sulbactam and Cefoperazone/Sulbactam Against Multidrug Resistant Acinetobacter Baumannii Infections in Critically Ill Patients","status":"RECRUITING","sponsor":"Cairo University","startDate":"2025-05-01","conditions":"Acinetobacter Baumannii Infection","enrollment":50},{"nctId":"NCT07107477","phase":"PHASE3","title":"TAILORED Therapeutic Regime in Patients With Preterm Premature Rupture Of Membranes to Prolong Pregnancy, Improve Maternal and Neonatal Outcomes, and Reduce Antibiotic Burden","status":"RECRUITING","sponsor":"The Central and Eastern European Gynecologic Oncology Group","startDate":"2025-05-01","conditions":"Preterm Premature Rupture of Membranes (PPROM)","enrollment":138},{"nctId":"NCT05922124","phase":"PHASE4","title":"Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii","status":"RECRUITING","sponsor":"Rambam Health Care Campus","startDate":"2024-09-01","conditions":"Carbapenem Resistant Bacterial Infection, Acinetobacter Bacteremia, Acinetobacter Pneumonia","enrollment":734},{"nctId":"NCT04198129","phase":"PHASE1","title":"The Evaluation of Postoperative Antibiotics in Non-Infected Mandible Fractures","status":"TERMINATED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2020-10-01","conditions":"Jaw Fractures, Infection","enrollment":13},{"nctId":"NCT01463540","phase":"PHASE4","title":"Gastrostomy Tube Placed After Gastropexy Versus Gastrostomy Tube Placed Using the Traditional Push/Pull Techniques","status":"COMPLETED","sponsor":"Azienda USL Reggio Emilia - IRCCS","startDate":"2010-09","conditions":"Gastrostomy, Methods","enrollment":206},{"nctId":"NCT06448624","phase":"PHASE4","title":"Biomarkers & Infection After Prophylactic Antibiotic in Cardiac Implantable Electronic Device Implantation","status":"COMPLETED","sponsor":"Universitas Diponegoro","startDate":"2024-04-01","conditions":"Heart Block, CIED Related Infection, CIED-related Infections","enrollment":60},{"nctId":"NCT06735703","phase":"","title":"Group B Streptococcus Infection and PROM Incidince","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-12-25","conditions":"Premature Rupture of Fetal Membranes, Group B Streptococcal Infection","enrollment":150},{"nctId":"NCT04724044","phase":"PHASE3","title":"Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia","status":"COMPLETED","sponsor":"Hellenic Institute for the Study of Sepsis","startDate":"2021-01-25","conditions":"Community-acquired Pneumonia, Sepsis, Inflammatory Response","enrollment":278},{"nctId":"NCT06048692","phase":"PHASE3","title":"Cefepime and Unictam on Preventing Post-Cesarean Surgical Site Infections","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-01-01","conditions":"Cesarean Section; Infection","enrollment":213},{"nctId":"NCT05164692","phase":"NA","title":"Effects of Nasal-spraying LiveSpo Navax in Treatment of Acute Respiratory Infections in Children","status":"COMPLETED","sponsor":"National Children's Hospital, Vietnam","startDate":"2020-08-29","conditions":"Acute Respiratory Tract Infections","enrollment":100},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":"Osteomyelitis","enrollment":11},{"nctId":"NCT04290104","phase":"PHASE4","title":"Is an Antibiotic Prescription Required After Laparoscopic Cholecystectomy","status":"UNKNOWN","sponsor":"Konya Meram State Hospital","startDate":"2020-10-15","conditions":"Cholecystitis; Acute, With Cholelithiasis","enrollment":2},{"nctId":"NCT03560232","phase":"PHASE4","title":"Noninferiority Comparison of Prophylactic Open Fracture Antimicrobial Regimens","status":"TERMINATED","sponsor":"Mercy Health Ohio","startDate":"2018-07-09","conditions":"Open Fracture, Post-Op Wound Infection","enrollment":17},{"nctId":"NCT03776409","phase":"","title":"Safety and Efficacy of Vancomycin Plus Beta-lactams","status":"COMPLETED","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2018-12-12","conditions":"Critical Illness","enrollment":700},{"nctId":"NCT01892488","phase":"PHASE4","title":"Study to Demonstrate That Antibiotics Are Not Needed in Moderate Acute Exacerbations of COPD","status":"COMPLETED","sponsor":"Hannover Medical School","startDate":"2013-06-07","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":295},{"nctId":"NCT01888822","phase":"PHASE4","title":"Antibiotic Prophylaxis in Laparoscopic Cholecystectomy","status":"TERMINATED","sponsor":"University of Roma La Sapienza","startDate":"2013-06","conditions":"Cholelithiasis","enrollment":138},{"nctId":"NCT01760109","phase":"PHASE4","title":"Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection","status":"COMPLETED","sponsor":"Xiangbei Welman Pharmaceutical Co., Ltd","startDate":"2011-07","conditions":"Respiratory Tract Infections, Urinary Tract Infections","enrollment":2000},{"nctId":"NCT00879190","phase":"PHASE2, PHASE3","title":"Ampicillin / Sulbactam vs. Ampicillin / Gentamicin for Treatment of Chorioamnionitis","status":"COMPLETED","sponsor":"Stanford University","startDate":"2009-05","conditions":"Chorioamnionitis","enrollment":92},{"nctId":"NCT00760006","phase":"PHASE2","title":"Preventing Complications in Cleft Palate Repair With Antibiotics","status":"COMPLETED","sponsor":"Joseph Losee","startDate":"2008-05","conditions":"Cleft Palates","enrollment":224},{"nctId":"NCT02007603","phase":"PHASE3","title":"Concentration of Ampicillin / Sulbactam and Amoxicillin / Clavulanic Acid in the Blood During Renal Replacement Therapy in Longterm Renal Replacement Therapy Patients","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2013-08","conditions":"Infection During Hemodialysis","enrollment":16},{"nctId":"NCT01793688","phase":"","title":"Special Use-Result Surveillance of Unasyn-S (Kit) for Intravenous Use - A Surveillance on High-dose (>6 g Daily) Administration -","status":"COMPLETED","sponsor":"Pfizer","startDate":"2013-03-12","conditions":"Pneumonia, Lung Abscess, Peritonitis","enrollment":982},{"nctId":"NCT01662765","phase":"NA","title":"Conservative Versus Surgical Treatment of Umbilical Pilonidal Disease","status":"COMPLETED","sponsor":"Medical Park Gaziantep Hospital","startDate":"2003-11","conditions":"Pilonidal Sinus, Sinus; Dermal, Pilonidal, Umbilical Granuloma","enrollment":84},{"nctId":"NCT01118403","phase":"PHASE4","title":"Antibiotic Prophylaxis for Early Ventilator-associated Pneumonia in Neurological Patients","status":"WITHDRAWN","sponsor":"Hospital Pablo Tobón Uribe","startDate":"2011-03","conditions":"Ventilator Associated Pneumonia","enrollment":""},{"nctId":"NCT00619580","phase":"","title":"Ampicillin-sulbactam Resistant E.Coli at UPMC","status":"WITHDRAWN","sponsor":"University of Pittsburgh","startDate":"2008-02","conditions":"Positive E Coli Infections","enrollment":""},{"nctId":"NCT00044746","phase":"PHASE4","title":"Study Evaluating the Safety and Efficacy of Piperacillin/Tazobactam and Ampicillin/Sulbactam in Patients With Diabetic Foot Infections","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2000-10","conditions":"Diabetes Mellitus, Diabetic Foot","enrollment":314},{"nctId":"NCT00356148","phase":"PHASE4","title":"The Efficacy of Prophylactic Antibiotic Administration During Breast Cancer Surgery in Overweight Patients.","status":"COMPLETED","sponsor":"Marmara University","startDate":"2003-10","conditions":"Breast Cancer","enrollment":372},{"nctId":"NCT00368537","phase":"PHASE4","title":"Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2006-09","conditions":"Skin Diseases, Bacterial","enrollment":550},{"nctId":"NCT01189487","phase":"PHASE3","title":"The Study of Unasyn-S 12g/Day for Community Acquired Pneumonia (CAP)","status":"COMPLETED","sponsor":"Pfizer","startDate":"2010-10","conditions":"Pneumonia, Bacterial","enrollment":47},{"nctId":"NCT01349738","phase":"","title":"Asymptomatic Bacteriuria & Risk of Urinary Tract Infection in Renal Transplants","status":"UNKNOWN","sponsor":"Rice, James C., M.D.","startDate":"2011-05","conditions":"Bacteriuria, Urinary Tract Infections, Asymptomatic Infections","enrollment":200},{"nctId":"NCT00630513","phase":"PHASE4","title":"T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam","status":"COMPLETED","sponsor":"University of Bologna","startDate":"2008-01","conditions":"Intra-Abdominal Infection","enrollment":142},{"nctId":"NCT00952796","phase":"PHASE4","title":"A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections","status":"COMPLETED","sponsor":"Kaohsiung Medical University Chung-Ho Memorial Hospital","startDate":"2009-01","conditions":"Intra-abdominal Infection","enrollment":100},{"nctId":"NCT00137007","phase":"PHASE4","title":"Zithromax EV in Community-Acquired Pneumonia (CAP)","status":"COMPLETED","sponsor":"Pfizer","startDate":"2003-11","conditions":"Pneumonia","enrollment":151},{"nctId":"NCT01138852","phase":"PHASE4","title":"Ampicillin/Sulbactam Versus Cefuroxime as Antimicrobial Prophylaxis for Cesarean Section","status":"COMPLETED","sponsor":"Attikon Hospital","startDate":"2004-07","conditions":"Surgical Site Infections","enrollment":176},{"nctId":"NCT01045902","phase":"PHASE3","title":"BAY12-8039, iv/Oral Pulmonary Abscess/Aspiration Pneumonia","status":"COMPLETED","sponsor":"Bayer","startDate":"2001-02","conditions":"Pneumonia, Aspiration, Lung Abscess","enrollment":139}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2107,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Unasyn"],"phase":"marketed","status":"active","brandName":"Ampicillin / sulbactam","genericName":"Ampicillin / sulbactam","companyName":"Medical University of Vienna","companyId":"medical-university-of-vienna","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ampicillin inhibits bacterial cell wall synthesis while sulbactam inhibits bacterial beta-lactamase enzymes, together restoring ampicillin's activity against beta-lactamase-producing bacteria. Used for Bacterial infections caused by beta-lactamase-producing organisms (skin and soft tissue infections, intra-abdominal infections, gynecological infections), Respiratory tract infections, Urinary tract infections.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1986-12-31T00:00:00.000Z","mah":"PFIZER","brand_name_local":"UNASYN","application_number":"NDA050608"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1988-11-25T00:00:00.000Z","mah":"PFIZER","brand_name_local":"UNASYN","application_number":"ANDA062901"}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}